Hurdles to Specialty Pharmacy Success Highlights SPT Week in Review
Top five articles of the week from Specialty Pharmacy Times.
Decline in cancer incidence rates most likely driven by modern antiretroviral therapies.
First of its kind pharmacy aligns a pharmacy benefit manager and a retail giant.
Multiple myeloma survivor seeks to empower patients by illustrating the value of human life.
Glecaprevir/pibrentasvir achieved 99% sustained virologic response rate in patients with chronic HCV with compensated cirrhosis.
Challenges to specialty pharmacy profits will need to be overcome for smaller pharmacies to survive.